MMP9 and ovarian carcinoma: In previous studies, we also found that TMEFF1 promotes the expression of N-cadherin, Vimentin, MMP2, and MMP9 in ovarian cancer cells, inhibits the expression of E-cadherin, and participates in the EMT process [10].